By F..L. Ochoa-González, J..C. Fernández-Ruiz, M..F. Romo-García and Dr J..E. Castañeda-Delgado Rheumatoid arthritis shows a prevalence of 0.5–1.6 % globally. The identification of biomarkers for early treatment response could aid in the fine tuning of therapy and therefore contribute to increased treatment efficacy and the timely use of biologicals when no response from disease-modifying anti-rheumatic […]